Andrew Oxtoby
2019
In 2019, Andrew Oxtoby earned a total compensation of $3M as Chief Commercial Officer at Aimmune Therapeutics.
Compensation breakdown
Bonus | $3,298 |
---|---|
Non-Equity Incentive Plan | $169,456 |
Option Awards | $1,972,710 |
Salary | $396,667 |
Stock Awards | $263,280 |
Other | $145,968 |
Total | $2,951,379 |
Oxtoby received $2M in option awards, accounting for 67% of the total pay in 2019.
Oxtoby also received $3.3K in bonus, $169.5K in non-equity incentive plan, $396.7K in salary, $263.3K in stock awards and $146K in other compensation.
Rankings
In 2019, Andrew Oxtoby's compensation ranked 4,158th out of 13,971 executives tracked by ExecPay. In other words, Oxtoby earned more than 70.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,158 | 70th |
Manufacturing | 1,514 | 73rd |
Chemicals And Allied Products | 530 | 76th |
Drugs | 446 | 76th |
Pharmaceutical Preparations | 342 | 75th |
Oxtoby's colleagues
We found four more compensation records of executives who worked with Andrew Oxtoby at Aimmune Therapeutics in 2019.